Literature DB >> 35124224

Dupilumab-associated arthralgia in patients with aspirin-exacerbated respiratory disease.

Lorena Miss Ozuna1, Tessa Ryan2, Jillian C Bensko2, Tanya M Laidlaw3, Kathleen M Buchheit4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35124224      PMCID： PMC8977235          DOI： 10.1016/j.anai.2022.01.036

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  10 in total

1.  Acute arthritis and arthralgia as an adverse drug reaction to dupilumab.

Authors:  L E M de Wijs; J D van der Waa; P H P de Jong; D J Hijnen
Journal:  Clin Exp Dermatol       Date:  2019-09-06       Impact factor: 3.470

2.  Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD.

Authors:  Tanya M Laidlaw; Joaquim Mullol; Chunpeng Fan; Donghui Zhang; Nikhil Amin; Asif Khan; Jingdong Chao; Leda P Mannent
Journal:  J Allergy Clin Immunol Pract       Date:  2019-04-04

3.  Dupilumab-associated arthralgia: an observational retrospective study in VigiBase®.

Authors:  B Chrétien; C Dolladille; J Alexandre; S Fedrizzi; V Lelong-Boulouard; J C Lambert; E Ezine
Journal:  Br J Dermatol       Date:  2021-04-07       Impact factor: 9.302

4.  Development of arthralgia during treatment with dupilumab in a patient with atopic dermatitis.

Authors:  Nobuyuki Arakawa; Tsuyoshi Inoue; Takayuki Tanji; Hiroo Amano
Journal:  J Dermatol       Date:  2021-05-14       Impact factor: 4.005

Review 5.  Aspirin-Exacerbated Respiratory Disease.

Authors:  Andrew A White; Donald D Stevenson
Journal:  N Engl J Med       Date:  2018-09-13       Impact factor: 91.245

6.  Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.

Authors:  Mario Castro; Jonathan Corren; Ian D Pavord; Jorge Maspero; Sally Wenzel; Klaus F Rabe; William W Busse; Linda Ford; Lawrence Sher; J Mark FitzGerald; Constance Katelaris; Yuji Tohda; Bingzhi Zhang; Heribert Staudinger; Gianluca Pirozzi; Nikhil Amin; Marcella Ruddy; Bolanle Akinlade; Asif Khan; Jingdong Chao; Renata Martincova; Neil M H Graham; Jennifer D Hamilton; Brian N Swanson; Neil Stahl; George D Yancopoulos; Ariel Teper
Journal:  N Engl J Med       Date:  2018-05-21       Impact factor: 91.245

7.  Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.

Authors:  Claus Bachert; Joseph K Han; Martin Desrosiers; Peter W Hellings; Nikhil Amin; Stella E Lee; Joaquim Mullol; Leon S Greos; John V Bosso; Tanya M Laidlaw; Anders U Cervin; Jorge F Maspero; Claire Hopkins; Heidi Olze; G Walter Canonica; Pierluigi Paggiaro; Seong H Cho; Wytske J Fokkens; Shigeharu Fujieda; Mei Zhang; Xin Lu; Chunpeng Fan; Steven Draikiwicz; Siddhesh A Kamat; Asif Khan; Gianluca Pirozzi; Naimish Patel; Neil M H Graham; Marcella Ruddy; Heribert Staudinger; David Weinreich; Neil Stahl; George D Yancopoulos; Leda P Mannent
Journal:  Lancet       Date:  2019-09-19       Impact factor: 79.321

8.  Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated.

Authors:  A V Sears; R T Woolf; E Gribaleva; W Abdelrahman; S Robbie; B Menon; B Kirkham; C H Smith; A E Pink
Journal:  Br J Dermatol       Date:  2021-02-28       Impact factor: 9.302

9.  Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.

Authors:  Daniel R Morales; Brian J Lipworth; Bruce Guthrie; Cathy Jackson; Peter T Donnan; Virginia H Santiago
Journal:  J Allergy Clin Immunol       Date:  2013-12-31       Impact factor: 10.793

10.  Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting.

Authors:  Nicole Bavaro; Deborah Gakpo; Anisha Mittal; Jillian C Bensko; Tanya M Laidlaw; Kathleen M Buchheit
Journal:  J Allergy Clin Immunol Pract       Date:  2021-02-22
  10 in total
  1 in total

1.  Adverse events for biologics in patients with CRSwNP: A meta-analysis.

Authors:  Yang Shen; Xia Ke; Suling Hong; Yucheng Yang
Journal:  Clin Transl Allergy       Date:  2022-06-15       Impact factor: 5.657
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.